The Organ Transplant System Improvement Act
Memo: Submitted to Staff of the U.S. Senate Committee on Finance
Policy
Disadvantaging Rivals: Vertical Integration in the Pharmaceutical Market
Briefing: Delivered to the Congressional Budget Office’s Panel of Health Advisors
Print:
In September, 2024, LDI Senior Fellow Abby Alpert, PhD briefed members of the Congressional Budget Office’s Panel of Health Advisors on the topic of vertical integration in the pharmaceutical market.
The briefing drew from Alpert’s research with a focus on Medicare Part D prescription drug plans and looked at the UnitedHealth-Catamaran merger in 2015 as a case study. Alpert found that premiums increased for non-vertically integrated insurers and that cost savings for the vertically integrated insurers were not passed through to enrollees in the form of lower premiums, and that vertical integration will reduce competition in the Medicare Part D market.
Views expressed by the researchers are their own and do not necessarily represent those of the University of Pennsylvania Health System (Penn Medicine) or the University of Pennsylvania.
More on Policy at LDI
Optimizing Health Care for the Maternal-Infant Dyad
Memo: Delivered to the Office of Pennsylvania State Senator Maria Collett
The State of Philadelphia’s Reproductive Health Care System: Hispanic and Latine Women’s Health
Testimony: Delivered to Philadelphia City Council’s Committee on Public Health and Human Services
The State of Philadelphia’s Reproductive Health Care System: The Reproductive Health Safety Net
Testimony: Delivered to Philadelphia City Council’s Committee on Public Health and Human Services
Medicare and Medicaid Programs; Repeal of Minimum Staffing Standards for Long-Term Care Facilities
Comment: Submitted to Centers for Medicare & Medicaid Services
Dually Eligible Medicare and Medicaid Beneficiaries Enrolled in a Chronic Condition Special Needs Plan (C-SNP)
Comment: Delivered to the Centers for Medicare & Medicaid Services (CMS)